UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 30, 2002
IMMUNOMEDICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12104 61-1009366
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
300 American Road, Morris Plains, New Jersey 07950
(Address of principalexecutive offices) (zip code)
Registrant's telephone number, including area code: (973) 605-8200
Not applicable
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of
Title 18, United States Code), dated September 30, 2002.
Item 9. Regulation FD Disclosure
On September 30, 2002, the Registrant filed its Annual Report on Form 10-K
for the fiscal year ended June 30, 2002 with the Securities and Exchange
Commission. In connection with the filing of the Form 10-K, attached hereto as
an exhibit are certifications of the Registrant's Chief Executive Officer and
Chief Financial Officer, as required by 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. These certifications
are being furnished herewith solely to accompany the Form 10-K, pursuant to 18
U.S.C. Section 1350, are not being filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, and are not to be incorporated by
reference into any of the Registrant's filings with the Securities and Exchange
Commission, whether filed prior to or after the furnishing of these
certifications, regardless of any general or specific incorporation language in
any such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
IMMUNOMEDICS, INC.
Date: September 30, 2002 /s/ CYNTHIA L. SULLIVAN
------------------------------
Cynthia L. Sullivan
President and Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
Number Description
- ------- -----------
99.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code), dated September 30, 2002.
4
Exhibit 99.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and
(b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the
undersigned officers of Immunomedics, Inc., a Delaware corporation (the
"Company"), does hereby certify, to such officer's knowledge, that:
The Form 10-K for the year ended June 30, 2002 (the "Form 10-K") of the Company
fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and the information contained in the Form 10-K fairly
presents, in all material respects, the financial condition and results of
operations of the Company.
Dated: September 30, 2002 /s/ Cynthia L. Sullivan
----------------------------------------
Cynthia L. Sullivan
President and Chief Executive Officer
Dated: September 30, 2002 /s/ Gerard G. Gorman
----------------------------------------
Gerard G. Gorman
Vice President, Finance and
Chief Financial Officer
The foregoing certification is being furnished solely pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter
63 of Title 18, United States Code) and is not being filed as part of a separate
disclosure document.
5